BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28259994)

  • 1. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.
    Bai S; Feng Q; Pan XY; Zou H; Chen HB; Wang P; Zhou XL; Hong YL; Song SL; Yang JL
    Int J Mol Med; 2017 Apr; 39(4):861-868. PubMed ID: 28259994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between expression of ras p21 oncoprotein and mutation status of the K-ras gene in sporadic colorectal cancer patients in Tunisia.
    Sammoud S; Khiari M; Semeh A; Amine L; Ines C; Amira A; Lilia K; Taher K; Sabeh M; Saadia B
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):146-52. PubMed ID: 21768877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Role of p53 and K-ras in the Diagnosis of Early Colorectal Cancer: a One-year, Single-center Analysis.
    Lu HY; Lin RT; Zhou GX; Yu TM; Liu ZJ
    Int J Med Sci; 2017; 14(11):1154-1162. PubMed ID: 29104470
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.
    Yang JL; Liu DX; Zhen SJ; Zhou YG; Zhang DJ; Yang LY; Chen HB; Feng Q
    BMC Cancer; 2016 Feb; 16():131. PubMed ID: 26897358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort.
    Levi M; Prayogi G; Sastranagara F; Sudianto E; Widjajahakim G; Gani W; Mahanadi A; Agnes J; Khairunisa BH; Utomo AR
    J Gastrointest Cancer; 2018 Jun; 49(2):124-131. PubMed ID: 28044264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.
    Zekri J; Al-Shehri A; Mahrous M; Al-Rehaily S; Darwish T; Bassi S; El Taani H; Al Zahrani A; Elsamany S; Al-Maghrabi J; Sadiq BB
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Field cancerization"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].
    Aivado M; Gynes M; Gorelov V; Schmidt WU; Röher HD; Goretzki PE
    Chirurg; 2000 Oct; 71(10):1230-4; discussion 1234-5. PubMed ID: 11077584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoreactivity of monoclonal anti-p21Ras antibody KGH-R1 in colorectal benign and malignant lesions].
    Chen HB; Liu DX; Wang L; Chen Y; Song SL; Yang LL; Hao Y; Yang JL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1206-9. PubMed ID: 21138685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
    Di Nicolantonio F; Martini M; Molinari F; Sartore-Bianchi A; Arena S; Saletti P; De Dosso S; Mazzucchelli L; Frattini M; Siena S; Bardelli A
    J Clin Oncol; 2008 Dec; 26(35):5705-12. PubMed ID: 19001320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
    Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
    Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.
    Ince WL; Jubb AM; Holden SN; Holmgren EB; Tobin P; Sridhar M; Hurwitz HI; Kabbinavar F; Novotny WF; Hillan KJ; Koeppen H
    J Natl Cancer Inst; 2005 Jul; 97(13):981-9. PubMed ID: 15998951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of annexin A1 is correlated with K-ras mutation in colorectal cancer.
    Su N; Xu XY; Chen H; Gao WC; Ruan CP; Wang Q; Sun YP
    Tohoku J Exp Med; 2010 Dec; 222(4):243-50. PubMed ID: 21127395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP.
    Lin P; Qian J; Huang CC; Xu WM; Wang YY; Gao ZR; Zheng SQ; Wang P; Jia DQ; Feng Q; Yang JL
    BMC Cancer; 2024 Jan; 24(1):71. PubMed ID: 38216883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers.
    Svrcek M; Buhard O; Colas C; Coulet F; Dumont S; Massaoudi I; Lamri A; Hamelin R; Cosnes J; Oliveira C; Seruca R; Gaub MP; Legrain M; Collura A; Lascols O; Tiret E; Fléjou JF; Duval A
    Gut; 2010 Nov; 59(11):1516-26. PubMed ID: 20947886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of epidermal growth factor receptor family receptors and ligands in a mutant K-ras group of patients with colorectal cancer.
    Nagaoka T; Kitaura K; Miyata Y; Kumagai K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
    Mol Med Rep; 2016 Apr; 13(4):3514-20. PubMed ID: 26935861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of microsatellite instability and K-ras mutation increases detection incidence of normal samples from colorectal cancer patients.
    Minamoto T; Esumi H; Ochiai A; Belitsky G; Mai M; Sugimura T; Ronai Z
    Clin Cancer Res; 1997 Aug; 3(8):1413-7. PubMed ID: 9815826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.